Listen to a preview of Drugs, Devices or Data - Which is Most Valuable? Webcast

Bio Companies Low on Venture Capital Cash

As the economy continues to retract, fewer biotech companies are finding the funding they need to survive, driving more firms to sell or close shop.

Pharma Steps Up to Help With Swine Flu

As the US government weighs its options on whether to commission a vaccine for the new H1N1 strain of influenza, pharma companies gear up for a possible epidemic.

Higher Learning for Pharma Sales Reps

American Society of Hypertension to launch new education program that grants sales reps hypertension accreditation after rigorous training.

Ortho-McNeil Launches Facebook Site for Adult ADHD

Ortho-McNeil is reaching out to the adult ADHD segment through the popular social networking site. The plan is to grow followers through education and unbranded information. Pharm Exec takes a look at the new site.

GSK Grabs Derma Firm for $2.9 Billion

Stiefel Labs is under new management. The dermatology company was purchased by GSK in an effort to bolster its existing skincare line.

US Pharma Market To Decline in 2009

IMS has revised its 2009, forecast and the outlook isn't pretty for the United States, which looks to drop 1 to 2 percent in the coming year.

Pfizer and Glaxo Join Forces in HIV Venture

The two pharma giants announced plans to form a new specialty company focused on HIV drug development. The new, independent firm will have a total of 11 drugs on the market, with another six on the horizon, securing its place as a powerhouse in the HIV market.

Search Ad Warnings Leave Pharma in Online Void

After last week’s flurry of FDA warning letters directed at companies marketing through search ads, industry is left wondering what can be done be done to target patients online?